Skip to main content

Table 1 Quarterly consumption of representative antibiotics and antibacterial compound classes

From: Intensive care antibiotic consumption and resistance patterns: a cross-correlation analysis

Time

DDD/1000 patient-days

Penicillins

Cephalosporins

Carbapenems

Fluoroquinolones

Aminoglycosides

Other

Piperacillin + tazobactam

Ampicillin + enzyme inhibitors

Amoxicillin  + enzyme inhibitors

Ceftriaxone

Cefuroxime

Imipenem + enzyme inhibitor

Meropenem

Ertapenem

Quarter I 2012

27.66

352.71

184.89

72.38

12.44

218.81

27.66

0.00

0.00

341.92

2.37

66.01

64.70

54.18

Quarter II 2012

36.99

265.39

183.44

81.03

29.42

242.46

10.69

18.33

7.96

222.05

35.42

58.73

74.24

50.47

Quarter III 2012

151.70

266.49

245.93

126.71

27.72

319.52

13.40

122.35

8.01

199.17

52.86

93.63

92.09

60.20

Quarter IV 2012

60.22

231.60

159.33

77.81

23.55

246.94

21.00

39.22

0.00

191.74

36.19

67.68

77.88

13.76

Quarter I 2013

118.27

184.84

222.13

73.13

8.29

273.84

53.35

50.48

7.53

99.17

73.45

64.67

113.67

43.79

Quarter II 2013

110.80

148.78

210.68

80.47

21.77

346.61

32.67

60.68

13.63

81.03

55.82

70.31

90.73

49.64

Quarter III 2013

138.16

232.97

270.24

77.04

25.98

339.51

71.43

57.50

8.76

137.83

63.18

55.34

172.22

42.67

Quarter IV 2013

139.90

241.57

286.46

88.46

40.49

468.93

102.33

36.05

0.00

127.11

17.71

97.50

165.75

23.21